Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at NOK 88.9M, followed by Belite Bio (NOK 97.8M) and Oruka Therapeutics (NOK 162.1M). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsNOK 88.9M
- Median
- NOK 20.2B
- Combined market value
- NOK 49.34T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | NOK 88.9M | NOK 51B | NOK 1,208.71 | 0.94% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | NOK 97.8M | NOK 62.8B | NOK 1,545.70 | 0.91% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | NOK 162.1M | NOK 63.6B | NOK 937.66 | 0.24% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | NOK 294.7M | NOK 43.4B | NOK 396.62 | 2.85% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | NOK 364.4M | NOK 47.2B | NOK 838.89 | 0.69% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | NOK 519.4M | NOK 78.9B | NOK 1,209.58 | 0.10% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | NOK 580.5M | NOK 82.7B | NOK 2,959.04 | 0.12% down | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | NOK 607.4M | NOK 87.8B | NOK 924.45 | 1.47% up | 286% up | ||
| 9 | ErascaERAS · Health Care | NOK 689.4M | NOK 45.1B | NOK 128.39 | 4.82% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | NOK 896.6M | NOK 83.1B | NOK 103.96 | 0.33% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | NOK 1B | NOK 37.9B | NOK 276.64 | 3.05% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | NOK 1.4B | NOK 71.1B | NOK 812.28 | 1.88% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | NOK 1.8B | NOK 72.6B | NOK 662.92 | 2.58% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.9B | NOK 73.3B | NOK 933.29 | 1.04% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 2B | NOK 78.6B | NOK 1,133.35 | 0.08% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | NOK 2.9B | NOK 48B | NOK 275.86 | 1.99% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | NOK 4B | NOK 94.7B | NOK 626.84 | 2.93% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | NOK 4B | NOK 272.7B | NOK 376.33 | 0.10% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 46.9B | NOK 488.11 | 1.64% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5.1B | NOK 57.7B | NOK 884.54 | 0.95% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | NOK 5.3B | NOK 58.2B | NOK 2,907.47 | 1.90% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | NOK 5.8B | NOK 68.2B | NOK 1,296.02 | 1.84% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 6.4B | NOK 92.4B | NOK 3,979.73 | 2.89% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | NOK 6.5B | NOK 76.1B | NOK 452.66 | 2.55% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | NOK 7.1B | NOK 30.6B | NOK 157.72 | 0.81% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | NOK 7.6B | NOK 237.7B | NOK 5,582.24 | 1.59% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8.6B | NOK 59.4B | NOK 420.51 | 0.72% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | NOK 14.6B | NOK 112.7B | NOK 581.63 | 2.36% up | 11% up | ||
| 29 | InsmedINSM · Health Care | NOK 14.8B | NOK 255.7B | NOK 1,165.44 | 1.52% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | NOK 15.8B | NOK 171.8B | NOK 2,619.69 | 0.53% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | NOK 20.2B | NOK 69.2B | NOK 496.85 | 0.95% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 20.6B | NOK 121.2B | NOK 145.40 | 1.23% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | NOK 29.3B | NOK 146.8B | NOK 753.53 | 1.03% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | NOK 29.5B | NOK 44.2B | NOK 265.37 | 1.35% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | NOK 30.1B | NOK 48.9B | NOK 585.81 | 0.07% down | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.7B | NOK 72.9B | NOK 209.09 | 1.94% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | NOK 37.2B | NOK 447.9B | NOK 3,921.46 | 2.29% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | NOK 40.6B | NOK 198.9B | NOK 1,484.81 | 2.31% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | NOK 66.1B | NOK 128B | NOK 256.05 | 1.99% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | NOK 67.8B | NOK 1.31T | NOK 5,181.83 | 0.12% down | 27% up | ||
| 41 | GenmabGMAB · Health Care | NOK 68.2B | NOK 307.3B | NOK 498.40 | 1.23% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 71.3B | NOK 151.8B | NOK 2,365.02 | 1.17% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | NOK 90.3B | NOK 958.8B | NOK 9,268.20 | 0.36% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | NOK 96.2B | NOK 382.2B | NOK 664.66 | 0.35% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | NOK 117.9B | NOK 330.5B | NOK 813.30 | 0.32% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | NOK 130.5B | NOK 56.4B | NOK 82.89 | 1.10% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | NOK 218.3B | NOK 230B | NOK 200.59 | 1.00% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 318.9B | NOK 478.8B | NOK 410.32 | 0.87% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | NOK 329.6B | NOK 1.75T | NOK 1,011.66 | 0.52% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | NOK 491.5B | NOK 662.8B | NOK 207.44 | 1.29% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | NOK 502.8B | NOK 1.7T | NOK 385.24 | 2.54% down | 17% down | ||
| 52 | GSKGSK · Health Care | NOK 582.2B | NOK 949.2B | NOK 473.54 | 0.97% down | 6% up | ||
| 53 | SanofiSNY · Health Care | NOK 593.7B | NOK 1.1T | NOK 459.31 | 0.49% down | 4% down | ||
| 54 | NovartisNVS · Health Care | NOK 625.4B | NOK 2.86T | NOK 1,516.18 | 1.89% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | NOK 634.7B | NOK 2.69T | NOK 1,735.42 | 1.96% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | NOK 694.7B | NOK 1.19T | NOK 582.31 | 2.27% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | NOK 817.8B | NOK 3.34T | NOK 1,354.63 | 2.71% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | NOK 834.6B | NOK 12.01T | NOK 13,480.47 | 1.94% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | NOK 1.14T | NOK 6.43T | NOK 2,671.96 | 1.28% down | 38% up | ||
| 60 | PfizerPFE · Health Care | NOK 1.18T | NOK 1.56T | NOK 273.38 | 1.12% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | NOK 1.33T | NOK 4.95T | NOK 2,798.99 | 1.57% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7116 NOK).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (NOK 88.9M), Belite Bio (NOK 97.8M) and Oruka Therapeutics (NOK 162.1M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of NOK 49.34T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.